![About us About us](/sites/default/files/styles/720_tablet_portrait_fallback/public/media_image-file/2023-04/About-us-banner.jpg?itok=gitrbpub)
![Mission-Icon](/sites/default/files/styles/card_style_fallback/public/media_image-file/2023-04/Mission-Icon-new.jpg?h=57024e64&itok=zC8kzzBo)
Our Mission
Advancing Cancer Diagnostics, Improving Lives
![Vision](/sites/default/files/styles/card_style_fallback/public/media_image-file/2023-04/Vision%20Icon.jpg?h=57024e64&itok=qBB0CnpA)
Our Vision
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Leica Biosystems and Navinci Partner to Accelerate Cancer Research Through First-Ever Fully Automated In Situ Proximity Ligation Assays
Leica Biosystems, a global leader in anatomic pathology, and Navinci, a leader in developing innovative solutions for studying protein interactions, announce a strategic collaboration to drive innovation in cancer patient care.
Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration.
Leica Biosystems Digital Pathology Solutions Offer Improved Image Quality and Flexible Scanning
Leica Biosystems enables researchers to accelerate their journey, transforming scientific exploration into translational outcomes, with a new digital pathology software release.
Leica Biosystems at a Glance
![About US](/sites/default/files/styles/720_tablet_portrait_fallback/public/media_image-file/2023-04/about-us-number.jpg?itok=BXfKVZt9)
150+ Years of Innovation
2012 - Present |
New Era of Science & Technology |
2005 - 2011 |
Global Expansion Accelerates |
1989 - 2004 |
Structuring for Comprehensive Workflow |
1930 - 1988 |
Novel Products Drive Company Growth |
1900 - 1930 |
Microtomy Technology Advances Amidst Wartime Realities |
1872 - 1899 |
The Creation of the Microtome and the Early Years of R. Jung GMBH |
About Danaher
Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.